Vitalpax Launches New Clinical Supplement Line

LA VERKIN, UT – Vitalpax is excited to announce the launch of their new clinically validated supplement line featuring 11 pharmacist-developed formulations. These products aim to provide consumers with more accessible and affordable health solutions, as opposed to OTC or prescription options which can be expensive or difficult to purchase.

With the rising cost of healthcare, more and more consumers are seeking alternative and affordable options for maintaining their health. According to a recent report by Peterson-KKF, more than 3 in 4 adults in the US think their medications have become unaffordable, and nearly 1 in 3 have been unable to access medication due to costs – and these prices are expected to continue to rise. This means that many consumers are finding it difficult to access the medications they need to maintain their health and wellbeing.

To address this issue, Vitalpax has developed a line of clinically validated supplements that are designed to provide effective and affordable health solutions. Each supplement includes ingredients that have been scientifically backed in studies, which have been shown to promote specific health benefits.

The product line includes the following supplements:

  • Heart Health
  • Glucose Support
  • Nerve Support
  • Cognitive Support
  • Memory Support
  • Sleep Support
  • Pain Management
  • Weight Management
  • Immunity Support
  • Kidney Support
  • Respiratory Health

“We are thrilled with this launch, which will provide more affordable options for consumers,” said Dalyon Ruesch, CEO of Vitalpax. “We understand that healthcare costs are increasing, and we believe that everyone should have access to clinically backed, premium health solutions without paying premium prices.”

To learn more about this new product line, visit to contact our sales team.


Vitalpax 是美国最大的优质保健品开发商和制造商之一。 Vitalpax 总部位于犹他州拉维尔金,是一家一站式商店,为全球客户提供各种胶囊、片剂、粉末和其他营养剂型的配方、开发、制造、包装和运输。该公司以其卓越的品质和创新而闻名,保持着行业最高水平,认可其卓越的制造标准,包括美国农业部有机认证和清真认证。如需更多信息,请访问。如需新闻或业务咨询,请通过 [email protected] 联系我们或致电 +1 (866) 844-2588。





单击编辑按钮更改此文本。 Lorem ipsum dolor sit amet, consectetur adipiscing elit